Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the MULTIX Impact C ceiling-mounted digital radiography (DR) system as well as the MULTIX Impact VA20, a new version of the established floor-mounted parent DR system. Economically priced, both systems expand access to high-quality imaging and enhance the patient experience.
The MULTIX Impact C and the MULTIX Impact VA20 possess an intuitive operating system, versatile wireless detectors, motorized tube heads, and a free-floating, flat tabletop for easier patient access. With the X-ray tube's touch user interface, the radiologic technologist can remain by the patient's side for longer periods. And when in the control room, the technologist can continuously monitor the patient via the myExam 2D camera.
The myExam Companion user interface on both systems provides proactive guidance to help technologists of any skill level navigate a radiography procedure. Combining available patient data with other user or machine-observable, patient-specific information, myExam Companion can identify optimal acquisition and reconstruction parameters for each patient and procedure.
With myExam Companion's camera-based Smart Virtual Ortho feature, the technologist can set the field of view and adjust exposure parameters on the touchscreen using a live camera image of the patient, so long-leg and full-spine examinations can be set up and performed more easily. The Auto Full-Spine and Auto Long-Leg Collimation features use automated, artificial intelligence-based body part detection and collimation to accelerate spine and leg examination workflows by analyzing the patient's contour and adjusting the collimator blades in under half a second.
"With this FDA clearance, Siemens Healthineers pushes the boundaries of what is possible in radiography," said Niral Patel, Vice-President of X-ray Products at Siemens Healthineers North America. "We can now deliver both floor-mounted and ceiling-mounted options with automation, artificial intelligence, and safety features that expand our customers' capabilities in digital radiography."
About Siemens
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion.
Back to HCB News
